CN112972766B - High mechanical strength silk fibroin-hydroxyapatite composite bone scaffold and preparation method thereof - Google Patents
High mechanical strength silk fibroin-hydroxyapatite composite bone scaffold and preparation method thereof Download PDFInfo
- Publication number
- CN112972766B CN112972766B CN202110197499.XA CN202110197499A CN112972766B CN 112972766 B CN112972766 B CN 112972766B CN 202110197499 A CN202110197499 A CN 202110197499A CN 112972766 B CN112972766 B CN 112972766B
- Authority
- CN
- China
- Prior art keywords
- silk fibroin
- hydroxyapatite
- solution
- composite bone
- bone scaffold
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 75
- 239000002131 composite material Substances 0.000 title claims abstract description 63
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims abstract description 62
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 108010022355 Fibroins Proteins 0.000 claims abstract description 59
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims abstract description 51
- 239000000243 solution Substances 0.000 claims abstract description 42
- 230000005684 electric field Effects 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 15
- 230000006698 induction Effects 0.000 claims abstract description 6
- 230000009471 action Effects 0.000 claims abstract description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 7
- 238000005119 centrifugation Methods 0.000 claims description 6
- 238000000502 dialysis Methods 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 241000255789 Bombyx mori Species 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims description 2
- 230000008014 freezing Effects 0.000 claims description 2
- 229910002804 graphite Inorganic materials 0.000 claims description 2
- 239000010439 graphite Substances 0.000 claims description 2
- 239000002105 nanoparticle Substances 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 abstract description 2
- 239000006185 dispersion Substances 0.000 abstract 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 14
- 238000010586 diagram Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 238000012512 characterization method Methods 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 238000011419 induction treatment Methods 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000002525 ultrasonication Methods 0.000 description 3
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000000278 osteoconductive effect Effects 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- -1 polytetrafluoroethylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
技术领域technical field
本发明涉及医学材料技术领域,尤其涉及一种高机械强度丝素蛋白-羟基磷灰石复合骨支架及其制备方法。The invention relates to the technical field of medical materials, in particular to a high mechanical strength silk fibroin-hydroxyapatite composite bone support and a preparation method thereof.
背景技术Background technique
骨骼是全球第二普遍移植的组织,每年至少进行四百万次手术,骨的缺损会给人的身体和生活带来极大的不便。虽然骨骼具有一定的再生能力,但是,在多数情况下仍需提高骨的修复能力。在临床上,对于骨缺损的治疗,常用自体骨移植或同种异体骨,但是存在免疫抗性、来源有限等问题。鉴于此,人们致力于研究出能模仿天然骨结构和性能的骨组织工程支架材料。近年来,由于其更好的生物相容性、多功能性等,人们对天然聚合物的关注越来越多,丝素作为一种具有生物相容性、易于加工成型、成本较低等各项优势的天然聚合物,被证实具有一定的骨修复性能。Bone is the second most commonly transplanted tissue in the world. At least 4 million operations are performed every year. Bone defects will bring great inconvenience to people's body and life. Although bone has a certain regenerative ability, in most cases, it is still necessary to improve the bone repair ability. In clinical practice, autologous bone transplantation or allogeneic bone is commonly used in the treatment of bone defects, but there are problems such as immune resistance and limited sources. In view of this, people are committed to researching bone tissue engineering scaffold materials that can mimic the structure and performance of natural bone. In recent years, people have paid more and more attention to natural polymers due to its better biocompatibility and multifunctionality. This advantageous natural polymer has been proven to have certain bone repair properties.
丝素是一种源于蚕丝的天然高分子材料,其在骨组织工程领域的研究和应用越来越多。目前,与天然骨相比,再生丝素制备的多孔支架力学性能和成骨性能较差,为了改善这一缺点,可以加入羟基磷灰石颗粒,更有效的模拟天然骨结构。羟基磷灰石是一种生物活性陶瓷,其化学组成和结晶结构类似于人体骨基质中无机物的主要组成组分。之前的研究表明,人工合成的羟基磷灰石与人体骨骼中的羟基磷灰石组成相同,结构相似,植入人体内无不良反应,具有良好的生物相容性,同时表现出一定的成骨诱导性和骨传导性。因此,以丝素蛋白为基质,掺入羟基磷灰石颗粒,可以制备力学性能和骨修复性能优异的支架。Silk fibroin is a natural polymer material derived from silk, and its research and application in the field of bone tissue engineering are increasing. At present, compared with natural bone, the mechanical properties and osteogenic properties of porous scaffolds prepared by regenerated silk fibroin are poor. In order to improve this shortcoming, hydroxyapatite particles can be added to more effectively simulate the natural bone structure. Hydroxyapatite is a bioactive ceramic whose chemical composition and crystal structure are similar to the main components of inorganic substances in human bone matrix. Previous studies have shown that artificially synthesized hydroxyapatite has the same composition and similar structure as hydroxyapatite in human bones, has no adverse reactions when implanted in the human body, has good biocompatibility, and exhibits a certain degree of osteogenesis Inductive and osteoconductive. Therefore, using silk fibroin as a matrix and incorporating hydroxyapatite particles, a scaffold with excellent mechanical properties and bone repair performance can be prepared.
目前,丝素/羟基磷灰石复合骨支架制备主要有两种方法,一是直接将丝素蛋白和羟基磷灰石机械混合,然后通过如粒滤、发泡、直接冷冻干燥等方法制备复合骨支架,二是制备好纯丝素蛋白支架,通过仿生矿化的方法引入羟基磷灰石。这些制备方法操作步骤多,得到的复合骨支架力学性能均比较差,不利于在临床上的使用。At present, there are two main methods for the preparation of silk fibroin/hydroxyapatite composite bone scaffolds. One is to directly mix silk fibroin and hydroxyapatite mechanically, and then prepare composite scaffolds by methods such as particle filtration, foaming, and direct freeze-drying. Bone scaffold, the second is to prepare a pure silk fibroin scaffold, and introduce hydroxyapatite through a biomimetic mineralization method. These preparation methods have many operation steps, and the mechanical properties of the obtained composite bone scaffolds are relatively poor, which is unfavorable for clinical use.
发明内容Contents of the invention
为解决上述技术问题,本发明通过直流定向电场诱导的方法,快速无毒的制备丝素/羟基磷灰石复合骨支架,制备周期短且操作简单,最终得到的支架具有优异并且可调节的力学性能。In order to solve the above-mentioned technical problems, the present invention rapidly and non-toxicly prepares silk fibroin/hydroxyapatite composite bone scaffold through the method of direct current directional electric field induction, the preparation cycle is short and the operation is simple, and the final scaffold has excellent and adjustable mechanical properties. performance.
本发明的第一个目的是提供了一种高机械强度丝素蛋白-羟基磷灰石复合骨支架的制备方法,包括如下步骤:The first object of the present invention is to provide a method for preparing a high mechanical strength silk fibroin-hydroxyapatite composite bone scaffold, comprising the following steps:
S1、将羟基磷灰石通过超声作用分散在水中,然后按照丝素蛋白与羟基磷灰石质量比10:0.5~5,向分散均匀的羟基磷灰石水溶液中加入丝素蛋白溶液,超声混合均匀,得到丝素/羟基磷灰石溶液;S1. Disperse hydroxyapatite in water by ultrasonic action, then add silk fibroin solution to the uniformly dispersed hydroxyapatite aqueous solution according to the mass ratio of silk fibroin to hydroxyapatite 10:0.5~5, and mix by ultrasonic Uniformly, obtain silk fibroin/hydroxyapatite solution;
S2、将两个石墨板插入丝素/羟基磷灰石溶液中,并分别连接直流电源的正负极,对丝素/羟基磷灰石溶液进行定向电场诱导作用,使得丝素蛋白溶液中自组装形成的纳米颗粒在正极板附近聚集成微米颗粒,并将羟基磷灰石包裹在里面,从而得到丝素/羟基磷灰石复合凝胶;S2. Insert two graphite plates into the silk fibroin/hydroxyapatite solution, and connect the positive and negative poles of the DC power supply respectively, and perform directional electric field induction on the silk fibroin/hydroxyapatite solution, so that the silk fibroin solution will automatically The assembled nano-particles are aggregated into micro-particles near the positive plate, and hydroxyapatite is wrapped inside to obtain a silk fibroin/hydroxyapatite composite gel;
S3、将丝素/羟基磷灰石复合凝胶预冷后进行冷冻干燥,得到所述的丝素蛋白-羟基磷灰石复合骨支架。S3. Pre-cooling the silk fibroin/hydroxyapatite composite gel and then freeze-drying to obtain the silk fibroin-hydroxyapatite composite bone scaffold.
进一步地,所述的定向电场诱导作用是在20~30V电压下处理10~40min。Further, the directional electric field induction is treated at a voltage of 20-30V for 10-40 minutes.
进一步地,所述的丝素溶液的浓度为5~10%wt%。Further, the concentration of the silk fibroin solution is 5-10% by weight.
进一步地,所述的丝素溶液通过如下方法进行制备:将蚕茧进行脱胶处理,脱胶后水洗、干燥,干燥后溶于LiBr溶液中,经过滤、透析、离心后获得丝素溶液。Further, the silk fibroin solution is prepared by the following method: degumming silkworm cocoons, washing and drying after degumming, dissolving in LiBr solution after drying, filtering, dialysis and centrifugation to obtain silk fibroin solution.
进一步地,所述的脱胶处理是将蚕茧至于0.1~1%w/v的NaHCO3溶液中,煮沸30~60min。Further, the degumming treatment is to put silkworm cocoons in 0.1-1% w/v NaHCO 3 solution and boil for 30-60 minutes.
进一步地,所述的LiBr溶液的浓度为9~10mol/L。Further, the concentration of the LiBr solution is 9-10 mol/L.
进一步地,所述的预冷是在-10~-30℃放置10~20h。Further, the pre-cooling is placed at -10 to -30°C for 10 to 20 hours.
进一步地,所述的冷冻干燥是在-80℃冷冻1~5h后采用冷冻干燥机进行冻干。Further, the freeze-drying is carried out by freezing at -80°C for 1-5 hours and then using a freeze-drying machine.
本发明的第二个目的是提供一种所述的方法制备得到的丝素蛋白-羟基磷灰石复合骨支架。The second object of the present invention is to provide a silk fibroin-hydroxyapatite composite bone scaffold prepared by the method.
本发明的第三个目的是提供所述的丝素蛋白-羟基磷灰石复合骨支架在制备人造骨骼中的应用。The third object of the present invention is to provide the application of the silk fibroin-hydroxyapatite composite bone scaffold in preparing artificial bones.
借由上述方案,本发明至少具有以下优点:By means of the above solution, the present invention has at least the following advantages:
本发明方法操作简单,制备周期短,并且环保、安全、无污染,制备得到的丝素/羟基磷灰石复合骨支架力学性能优异,能够达到临床使用要求。The method of the invention has simple operation, short preparation period, environmental protection, safety and no pollution, and the prepared silk fibroin/hydroxyapatite composite bone scaffold has excellent mechanical properties and can meet the requirements of clinical use.
上述说明仅是本发明技术方案的概述,为了能够更清楚了解本发明的技术手段,并可依照说明书的内容予以实施,以下以本发明的较佳实施例并配合详细附图说明如后。The above description is only an overview of the technical solutions of the present invention. In order to understand the technical means of the present invention more clearly and implement them according to the contents of the description, the preferred embodiments of the present invention are described below with detailed drawings.
附图说明Description of drawings
图1为电场作用下制备丝素/羟基磷灰石复合骨支架示意图;Fig. 1 is the schematic diagram of preparing silk fibroin/hydroxyapatite composite bone scaffold under the action of electric field;
图2为两种复合骨支架的电镜图;Fig. 2 is the electron microscope picture of two kinds of composite bone scaffolds;
图3为两种复合骨支架的红外表征图;Fig. 3 is the infrared characterization diagram of two kinds of composite bone scaffolds;
图4为两种复合骨支架的XRD表征图;Fig. 4 is the XRD characterization figure of two kinds of composite bone scaffolds;
图5为两种复合骨支架的机械性能对比图;Fig. 5 is the comparison diagram of the mechanical properties of two kinds of composite bone scaffolds;
图6为电场复合骨支架与松骨质以及参考文献中的丝素蛋白/羟基磷灰石复合骨支架的机械性能比较图。Fig. 6 is a comparison diagram of the mechanical properties of the electric field composite bone scaffold and cancellous bone and the silk fibroin/hydroxyapatite composite bone scaffold in the reference.
具体实施方式Detailed ways
下面结合实施例,对本发明的具体实施方式作进一步详细描述。以下实施例用于说明本发明,但不用来限制本发明的范围。Below in conjunction with the examples, the specific implementation of the present invention will be further described in detail. The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.
复合骨支架做压缩力学性能测试方法:Composite bone scaffold for compression mechanical properties test method:
用聚四氟乙烯模具将支架制备成尺寸为10mm(直径)×8mm(高)的圆柱形,使用质构仪(TMS-PRO)对样品进行压缩力学性能测试。测试速度设置为10mm/min,触发力为0.03N,压缩比为80%,每组测试三个样品。A polytetrafluoroethylene mold was used to prepare the scaffold into a cylindrical shape with a size of 10 mm (diameter) × 8 mm (height), and a texture analyzer (TMS-PRO) was used to test the compressive mechanical properties of the sample. The test speed is set at 10mm/min, the trigger force is 0.03N, the compression ratio is 80%, and three samples are tested in each group.
实施例1:Example 1:
按照图1的示意图,制备复合骨支架:According to the schematic diagram in Figure 1, prepare the composite bone scaffold:
1、将蚕茧剪成大约1cm2的茧片,称取一定量的蚕茧茧片,放入到含有0.5%w/v的NaHCO3溶液中,煮沸45min后,用温的去离子水对脱胶丝进行冲洗4-5次,干燥后将丝素溶于9.3mol/L的LiBr溶液中,60℃下溶解1h。经过滤、透析、离心后获得最终浓度约为9wt%的丝素溶液。1. Cut the cocoon into cocoon pieces of about 1cm2 , weigh a certain amount of cocoon cocoon pieces, put them into the NaHCO 3 solution containing 0.5% w/v, boil for 45min, and use warm deionized water to degummed silk Rinse 4-5 times, and after drying, dissolve silk fibroin in 9.3 mol/L LiBr solution and dissolve at 60°C for 1 hour. After filtration, dialysis and centrifugation, a silk fibroin solution with a final concentration of about 9wt% was obtained.
2、按质量分数丝素:羟基磷灰石=10:2的比例将羟基磷灰石先分散在一定的水中,后加入丝素,经过超声使两者混合均匀。2. According to the mass fraction of silk fibroin: hydroxyapatite = 10:2, the hydroxyapatite is first dispersed in a certain amount of water, then the silk fibroin is added, and the two are mixed evenly by ultrasonication.
3、在25V的电压下,进行丝素/羟基磷灰石溶液的直流定向电场诱导处理(约20~30min)。3. Under the voltage of 25V, conduct direct current directional electric field induction treatment of silk fibroin/hydroxyapatite solution (about 20-30min).
4、取出丝素/羟基磷灰石复合凝胶,放在-20℃下过夜,后经-80℃冷冻4h,放入冷冻干燥机冻干。4. Take out the silk fibroin/hydroxyapatite composite gel, put it at -20°C overnight, then freeze it at -80°C for 4 hours, and put it into a freeze dryer to freeze dry.
5、取出冻干支架,得到复合骨支架。5. Take out the freeze-dried scaffold to obtain a composite bone scaffold.
实施例2:Example 2:
1、将蚕茧剪成大约1cm2的茧片,称取一定量的蚕茧茧片,放入到含有0.5%w/v的NaHCO3溶液中,煮沸45min后,用温的去离子水对脱胶丝进行冲洗4-5次,干燥后将丝素溶于9.3mol/L的LiBr溶液中,60℃下溶解1h。经过滤、透析、离心后获得最终浓度约为9wt%的丝素溶液。1. Cut the cocoon into cocoon pieces of about 1cm2 , weigh a certain amount of cocoon cocoon pieces, put them into the NaHCO 3 solution containing 0.5% w/v, boil for 45min, and use warm deionized water to degummed silk Rinse 4-5 times, and after drying, dissolve silk fibroin in 9.3 mol/L LiBr solution and dissolve at 60°C for 1 hour. After filtration, dialysis and centrifugation, a silk fibroin solution with a final concentration of about 9wt% was obtained.
2、按质量分数丝素:羟基磷灰石=10:1的比例将羟基磷灰石先分散在一定的水中,后加入丝素,经过超声使两者混合均匀。2. According to the mass fraction of silk fibroin: hydroxyapatite = 10:1, the hydroxyapatite is first dispersed in a certain amount of water, then the silk fibroin is added, and the two are mixed evenly by ultrasonication.
3、在20V的电压下,进行丝素/羟基磷灰石溶液的直流定向电场诱导处理(约30~40min)。3. Under the voltage of 20V, conduct direct current directional electric field induction treatment of silk fibroin/hydroxyapatite solution (about 30-40min).
4、取出丝素/羟基磷灰石复合凝胶,放在-20℃下过夜,后经-80℃冷冻4h,放入冷冻干燥机冻干。4. Take out the silk fibroin/hydroxyapatite composite gel, put it at -20°C overnight, then freeze it at -80°C for 4 hours, and put it into a freeze dryer to freeze dry.
5、取出冻干支架,得到复合骨支架。5. Take out the freeze-dried scaffold to obtain a composite bone scaffold.
实施例3:Example 3:
1、将蚕茧剪成大约1cm2的茧片,称取一定量的蚕茧茧片,放入到含有0.5%w/v的NaHCO3溶液中,煮沸45min后,用温的去离子水对脱胶丝进行冲洗4-5次,干燥后将丝素溶于9.3mol/L的LiBr溶液中,60℃下溶解1h。经过滤、透析、离心后获得最终浓度约为9wt%的丝素溶液。1. Cut the cocoon into cocoon pieces of about 1cm2 , weigh a certain amount of cocoon cocoon pieces, put them into the NaHCO 3 solution containing 0.5% w/v, boil for 45min, and use warm deionized water to degummed silk Rinse 4-5 times, and after drying, dissolve silk fibroin in 9.3 mol/L LiBr solution and dissolve at 60°C for 1 hour. After filtration, dialysis and centrifugation, a silk fibroin solution with a final concentration of about 9wt% was obtained.
2、按质量分数丝素:羟基磷灰石=10:3的比例将羟基磷灰石先分散在一定的水中,后加入丝素,经过超声使两者混合均匀。2. According to the ratio of mass fraction silk fibroin: hydroxyapatite = 10:3, the hydroxyapatite is first dispersed in a certain amount of water, then the silk fibroin is added, and the two are mixed evenly through ultrasonication.
3、在30V的电压下,进行丝素/羟基磷灰石溶液的直流定向电场诱导处理(约30~40min)。3. Under the voltage of 30V, conduct direct current directional electric field induction treatment of silk fibroin/hydroxyapatite solution (about 30-40min).
4、取出丝素/羟基磷灰石复合凝胶,放在-20℃下过夜,后经-80℃冷冻4h,放入冷冻干燥机冻干。4. Take out the silk fibroin/hydroxyapatite composite gel, put it at -20°C overnight, then freeze it at -80°C for 4 hours, and put it into a freeze dryer to freeze dry.
5、取出冻干支架,得到复合骨支架。5. Take out the freeze-dried scaffold to obtain a composite bone scaffold.
对比例1:Comparative example 1:
1、将蚕茧剪成大约1cm2的茧片,称取一定量的蚕茧茧片,放入到含有0.5%w/v的NaHCO3溶液中,煮沸45min后,用温的去离子水对脱胶丝进行冲洗4-5次,干燥后将丝素溶于9.3mol/L的LiBr溶液中,60℃下溶解1h。经过滤、透析、离心后获得最终浓度约为9wt%的丝素溶液。1. Cut the cocoon into cocoon pieces of about 1cm2 , weigh a certain amount of cocoon cocoon pieces, put them into the NaHCO 3 solution containing 0.5% w/v, boil for 45min, and use warm deionized water to degummed silk Rinse 4-5 times, and after drying, dissolve silk fibroin in 9.3 mol/L LiBr solution and dissolve at 60°C for 1 hour. After filtration, dialysis and centrifugation, a silk fibroin solution with a final concentration of about 9wt% was obtained.
2、按质量分数丝素:羟基磷灰石=10:2的比例,先将羟基磷灰石先分散在一定的丁醇溶液中,经超声混匀,逐滴加入丝素溶液中,边加边混匀溶液。2. According to the ratio of mass fraction silk fibroin: hydroxyapatite = 10:2, first disperse the hydroxyapatite in a certain butanol solution, mix well by ultrasonic, add dropwise into the silk fibroin solution, and add While mixing the solution.
3、将混合好的溶液放在-20℃下过夜,后经-80℃冷冻4h,放入冷冻干燥机冻干。3. Put the mixed solution at -20°C overnight, then freeze at -80°C for 4 hours, and put it into a freeze dryer to freeze dry.
4、取出冻干支架,得到复合骨支架。4. Take out the freeze-dried scaffold to obtain the composite bone scaffold.
对比实施例1和对比例1得到的复合骨支架的性能,结果如下:The performance of the composite bone scaffold obtained by comparative example 1 and comparative example 1, the results are as follows:
图2为两种复合骨支架的电镜图,结果显示:两种复合骨支架均呈现出多孔结构,丁醇复合骨支架孔径较均匀,大小为50-100μm。电场复合骨支架的孔径大多集中在0-50μm,同时出现了一些200-300μm的大孔,表现出一种多级多孔结构。Figure 2 is the electron micrographs of two kinds of composite bone scaffolds, and the results show that both composite bone scaffolds exhibit porous structures, and the pore diameter of the butanol composite bone scaffolds is relatively uniform, with a size of 50-100 μm. The pore size of the electric field composite bone scaffold is mostly concentrated in 0-50 μm, and some large pores of 200-300 μm appear at the same time, showing a multi-level porous structure.
图3为两种复合骨支架的红外表征图,结果显示:丁醇复合骨支架材料酰胺I的FTIR吸收峰主要出现在1621cm-1处,表明丁醇复合骨支架材料中丝素蛋白以β-折叠为主,而电场复合骨支架材料酰胺I的FTIR吸收峰主要出现在1637cm-1处,表明电场复合骨支架材料中丝素蛋白以无规卷曲为主。两种复合骨支架均在1030cm-1,600cm-1,560cm-1处有吸收峰,这与羟基磷灰石中的PO4 3-基团相对应,说明羟基磷灰石成功复合在丝素蛋白支架中。Fig. 3 is the infrared characterization figure of two kinds of composite bone scaffolds, the result shows: the FTIR absorption peak of butanol composite bone scaffold material amide I mainly appears at 1621cm Folding is the main factor, while the FTIR absorption peak of amide I of the electric field composite bone scaffold material mainly appears at 1637cm -1 , indicating that the silk fibroin in the electric field composite bone scaffold material is dominated by random coils. Both composite bone scaffolds have absorption peaks at 1030cm -1 , 600cm -1 , and 560cm -1 , which correspond to the PO 4 3- group in hydroxyapatite, indicating that hydroxyapatite is successfully compounded on silk fibroin in the protein scaffold.
图4为两种复合骨支架的XRD表征图,结果显示:两种不同方法制备的复合骨支架,均在26°、31.7°、33°、34°处出现特征峰,分别对应羟基磷灰石的(002)、(211)、(300)、(202)晶面。其结果与红外均表明两种方法都成功制备了丝素蛋白/羟基磷灰石复合骨支架。Figure 4 shows the XRD characterization diagrams of two kinds of composite bone scaffolds. The results show that the composite bone scaffolds prepared by two different methods all have characteristic peaks at 26°, 31.7°, 33°, and 34°, corresponding to hydroxyapatite respectively. (002), (211), (300), (202) crystal planes. Both the results and IR showed that the silk fibroin/hydroxyapatite composite bone scaffolds were successfully prepared by both methods.
图5为两种复合骨支架的机械性能对比图,结果显示:与丁醇复合骨支架相比,电场复合骨支架的抗压强度大幅度提高。Figure 5 is a comparison chart of the mechanical properties of the two composite bone scaffolds, and the results show that: compared with the butanol composite bone scaffold, the compressive strength of the electric field composite bone scaffold is greatly improved.
表1为两种复合骨支架的最大压缩强度和弹性模量,结果显示:与丁醇复合骨支架相比,电场复合骨支架的最大压缩强力和弹性模量都有大幅度提升,分别达到丁醇复合骨支架的14倍和21倍。Table 1 shows the maximum compressive strength and elastic modulus of the two composite bone scaffolds. The results show that compared with the butanol composite bone scaffolds, the maximum compressive strength and elastic modulus of the electric field composite bone scaffolds have been greatly improved, respectively reaching butanol composite bone scaffolds. 14 times and 21 times that of alcohol composite bone scaffold.
表1Table 1
图6为电场复合骨支架与松骨质以及参考文献中的一些丝素蛋白/羟基磷灰石复合骨支架的机械性能比较图,结果显示:电场复合骨支架的机械性能比大多参考文献中都有较大提高,并且达到天然松质骨的机械性能要求,可以满足临床上的应用,是一种有效的新策略。Figure 6 is a comparison of the mechanical properties of the electric field composite bone scaffold with cancellous bone and some silk fibroin/hydroxyapatite composite bone scaffolds in the references. The results show that the mechanical properties of the electric field composite bone scaffold are better than most of the references. It has been greatly improved, and meets the mechanical properties requirements of natural cancellous bone, which can meet the clinical application, and is an effective new strategy.
以上仅是本发明的优选实施方式,并不用于限制本发明,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明技术原理的前提下,还可以做出若干改进和变型,这些改进和变型也应视为本发明的保护范围。The above are only preferred embodiments of the present invention, and are not intended to limit the present invention. It should be pointed out that for those of ordinary skill in the art, some improvements and modifications can be made without departing from the technical principles of the present invention. , these improvements and modifications should also be regarded as the protection scope of the present invention.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110197499.XA CN112972766B (en) | 2021-02-22 | 2021-02-22 | High mechanical strength silk fibroin-hydroxyapatite composite bone scaffold and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110197499.XA CN112972766B (en) | 2021-02-22 | 2021-02-22 | High mechanical strength silk fibroin-hydroxyapatite composite bone scaffold and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112972766A CN112972766A (en) | 2021-06-18 |
| CN112972766B true CN112972766B (en) | 2023-02-28 |
Family
ID=76349284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110197499.XA Active CN112972766B (en) | 2021-02-22 | 2021-02-22 | High mechanical strength silk fibroin-hydroxyapatite composite bone scaffold and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112972766B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023134090A1 (en) * | 2022-01-13 | 2023-07-20 | Shenzhen Institute Of Advanced Technology | Use of a neuropeptide in treating bone-injury disease |
| CN116173310B (en) * | 2023-02-24 | 2024-12-24 | 苏州大学 | A polymer/hydroxyapatite composite scaffold with highly ordered interconnected porous structure and its preparation method and application |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106866996A (en) * | 2017-03-13 | 2017-06-20 | 武汉纺织大学 | A kind of fast preparation method of silk fibroin matter gel |
| CN107761148A (en) * | 2016-08-22 | 2018-03-06 | 张贞 | A kind of method that fibroin albumen hydroxyapatite coating layer is prepared in metal surface |
| CN110917400A (en) * | 2019-12-05 | 2020-03-27 | 中山大学 | Nano-hybrid silk fibroin hydrogel and preparation method and application thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8501172B2 (en) * | 2008-09-26 | 2013-08-06 | Trustees Of Tufts College | pH-induced silk gels and uses thereof |
-
2021
- 2021-02-22 CN CN202110197499.XA patent/CN112972766B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107761148A (en) * | 2016-08-22 | 2018-03-06 | 张贞 | A kind of method that fibroin albumen hydroxyapatite coating layer is prepared in metal surface |
| CN106866996A (en) * | 2017-03-13 | 2017-06-20 | 武汉纺织大学 | A kind of fast preparation method of silk fibroin matter gel |
| CN110917400A (en) * | 2019-12-05 | 2020-03-27 | 中山大学 | Nano-hybrid silk fibroin hydrogel and preparation method and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| "Non-equilibrium silk fibroin adhesives";Tuna Yucel等;《Journal of Structural Biology》;20091221;第170卷;第406-412页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112972766A (en) | 2021-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109999227B (en) | Preparation method and application of silk fibroin and chitin-based blended nanofiber embedded hydrogel cartilage bionic scaffold | |
| CN103341209B (en) | Silk fibroin nanofiber membrane and preparation method thereof | |
| CN112972766B (en) | High mechanical strength silk fibroin-hydroxyapatite composite bone scaffold and preparation method thereof | |
| CN106243376A (en) | A kind of silk fibroin nano-fiber porous support and preparation method thereof | |
| CN113577392B (en) | Artificial periosteum of composite acellular periosteum matrix and preparation method and application thereof | |
| CN102552985B (en) | Silk fibroin/calcium phosphate bone cement-based porous composite material and preparation method thereof | |
| CN110665055B (en) | Sericin/nano-hydroxyapatite tissue engineering bone graft and preparation method and application thereof | |
| Chen et al. | Nanohydroxyapatite/cellulose nanocrystals/silk fibroin ternary scaffolds for rat calvarial defect regeneration | |
| CN111962210A (en) | Polycaprolactone/methacryloylated elastin nanofiber composite membrane and preparation method and application thereof | |
| CN107537063B (en) | A composite porous scaffold containing carbon nanotubes and its preparation method | |
| CN118615489A (en) | Tendon repair material with antioxidant and antibacterial activity, preparation method and application thereof | |
| CN118767212A (en) | Preparation of a porous artificial bone composite of silk fibroin hydroxyapatite and hyaluronic acid | |
| CN113332497B (en) | A double-sided stent and its preparation method and application | |
| JP5301565B2 (en) | Biomaterial manufacturing method | |
| CN113694254A (en) | Bone repair material, preparation method and application thereof | |
| CN117159801A (en) | Preparation method of nanometer composite hydrogel scaffold for promoting bone tissue regeneration by slowly releasing OPG and SDF-1 | |
| CN110354315B (en) | Preparation method of three-dimensional porous antibacterial silk fibroin/graphene/titanium dioxide bone tissue engineering scaffold | |
| CN1836740A (en) | Composite tri-dimensional porous bone tissue engineering stent material and its preparation method and uses | |
| CN117180506B (en) | Bracket for treating infectious bone defect and preparation method and application thereof | |
| CN116173295A (en) | A biomimetic mineralized silk fibroin scaffold material and its preparation method and application | |
| CN113952512B (en) | A kind of composite porous gel microsphere and its preparation method and application | |
| CN103920187B (en) | The bone renovating material that a kind of fibroin albumen and decalcified bone matrix are compound | |
| CN103495204B (en) | Extracellular full-matrix loaded chitosan/nano-hydroxyapatite sustained release microsphere and preparation method thereof | |
| CN117659442A (en) | Silk fibroin gel and preparation method thereof | |
| CN114984326B (en) | A multiple cross-linked injectable bone repair hydrogel preparation material and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |